Noncanonical Roles of RAD51

Cells. 2023 Apr 15;12(8):1169. doi: 10.3390/cells12081169.

Abstract

Homologous recombination (HR), an evolutionary conserved pathway, plays a paramount role(s) in genome plasticity. The pivotal HR step is the strand invasion/exchange of double-stranded DNA by a homologous single-stranded DNA (ssDNA) covered by RAD51. Thus, RAD51 plays a prime role in HR through this canonical catalytic strand invasion/exchange activity. The mutations in many HR genes cause oncogenesis. Surprisingly, despite its central role in HR, the invalidation of RAD51 is not classified as being cancer prone, constituting the "RAD51 paradox". This suggests that RAD51 exercises other noncanonical roles that are independent of its catalytic strand invasion/exchange function. For example, the binding of RAD51 on ssDNA prevents nonconservative mutagenic DNA repair, which is independent of its strand exchange activity but relies on its ssDNA occupancy. At the arrested replication forks, RAD51 plays several noncanonical roles in the formation, protection, and management of fork reversal, allowing for the resumption of replication. RAD51 also exhibits noncanonical roles in RNA-mediated processes. Finally, RAD51 pathogenic variants have been described in the congenital mirror movement syndrome, revealing an unexpected role in brain development. In this review, we present and discuss the different noncanonical roles of RAD51, whose presence does not automatically result in an HR event, revealing the multiple faces of this prominent actor in genomic plasticity.

Keywords: Fanconi anemia; RAD51; RNA:DNA hybrids; cancer predisposition; congenital mirror syndrome; double-strand break repair; genome instability; homologous recombination; post-replication repair; replication stress.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • DNA / metabolism
  • DNA Repair*
  • DNA Replication
  • DNA, Single-Stranded
  • DNA-Binding Proteins / metabolism
  • Humans
  • Rad51 Recombinase* / genetics

Substances

  • DNA
  • DNA, Single-Stranded
  • DNA-Binding Proteins
  • Rad51 Recombinase

Grants and funding

This research was funded by grants from the Fondation ARC (ARCPJA2021060003792 and ARCPJA2022060005157), ITMO Cancer (PCSI 2022), INCa (Institut National du Cancer 2018-1-PLBIO-07 and PLBIO21-072), ANR (ANR-18-CE16-0005-02 MOMIC) and LABEX Who Am I? (ANR-11-LABX-0071; Idex ANR-11-IDEX-0005-02).